Aspen aims to sharply increase Covid-19 vaccine capacity
SA's Aspen Pharmacare is aiming to ramp up its Covid-19 vaccine manufacturing capacity to 1.3-billion doses a year by February 2024, up from a current annual output of about 250-million doses, the company's CEO said on Monday.
SA's Aspen Pharmacare is aiming to ramp up its Covid-19 vaccine manufacturing capacity to 1.3-billion doses a year by February 2024, up from a current annual output of about 250-million doses, the company's CEO said on Monday.
What's Your Reaction?
